Free public records show Sahajanand Medical Technologies Limited in 2 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Sahajanand Medical Technologies Limited or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
4 active studies led by Sahajanand Medical Technologies Limited, of 12 in all
Source: ClinicalTrials.gov, Studies with Sahajanand Medical Technologies Limited (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies Sahajanand Medical Technologies Limited leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Sahajanand Medical Technologies Limited or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Sahajanand Medical Technologies Limited: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Sahajanand Medical Technologies Limited is in.
Stories on the topics Sahajanand Medical Technologies Limited works in.
Omega-3 supplements are hugely popular. Big trials give mixed answers on whether they protect the heart.
Read
Cardiovascular disease is the world's leading cause of death, and stroke caused 11.9 million new cases in…
Read
2.4 billion people live with a condition that could benefit from rehabilitation. The need rose 63% since 1990.
ReadSearch all reports for Sahajanand Medical Technologies Limited All companies